Neurocrine Biosciences Announces Conference Call and Webcast to Present
First Quarter 2004 Financial Results
First Quarter 2004 Financial Results
Management Will Also Provide Company Update
SAN DIEGO, April 22 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report first quarter 2004 financial results after the Nasdaq market closes Tuesday, May 4, 2004. Neurocrine will also host a live conference call and Webcast to discuss its first quarter financial results and provide a Company update Wednesday morning, May 5, 2004 at 11:00 AM Eastern Daylight Time (EDT) / 8:00 AM Pacific Daylight Time (PDT). Participants may access the live Conference Call by dialing 1-800-905-0392 (U.S.) or 1-785-832-0326 (International). The call can also be accessed via the Webcast through the Company's website at http://www.neurocrine.com or alternatively through a link provided by PRNewswire at http://www.firstcallevents.com/service/ajwz405325797gf12.html.
Members from Neurocrine's senior management team will present the Company's first quarter 2004 financial results and provide an update on the Company's clinical programs. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-888-567-0677 (US) or 1-402-530-0419 (International) and will be archived until Wednesday, May 19, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.